Evidence map›Paper›PMID 33808733›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Novel Seleno- and Thio-Urea Containing Dihydropyrrol-2-One Analogues as Antibacterial Agents.

Shekh Sabir, Tsz Tin Yu, Rajesh Kuppusamy, Basmah Almohaywi, George Iskander, Theerthankar Das, Mark D P Willcox, David StClair Black, Naresh Kumar

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Organoselenium compounds beyond antioxidants.Future medicinal chemistry · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Shekh SabirSchool of Chemistry, The University of New South Wales, Sydney, NSW 2052, Australia.ORCID 0000-0002-3962-3040
Tsz Tin YuSchool of Chemistry, The University of New South Wales, Sydney, NSW 2052, Australia.ORCID 0000-0002-8484-7342
Rajesh KuppusamySchool of Chemistry, The University of New South Wales, Sydney, NSW 2052, Australia.ORCID 0000-0001-9844-5064
Basmah AlmohaywiDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia.
George IskanderSchool of Chemistry, The University of New South Wales, Sydney, NSW 2052, Australia.
Theerthankar DasDepartment of Infectious Diseases and Immunology, School of Medical Sciences, The University of Sydney, Sydney, NSW 2006, Australia.
Mark D P WillcoxSchool of Optometry and Vision Science, The University of New South Wales, Sydney, NSW 2052, Australia.ORCID 0000-0003-3842-7563
David StClair BlackSchool of Chemistry, The University of New South Wales, Sydney, NSW 2052, Australia.ORCID 0000-0001-9300-4737
Naresh KumarSchool of Chemistry, The University of New South Wales, Sydney, NSW 2052, Australia.
UNSW Sydney · AUKing Khalid University · SAThe University of Sydney · AU

Funding

Australian Research Council DP180100845
6 · The paper itself

Abstract

The quorum sensing (QS) system in multi-drug-resistant bacteria such as

Indexed as

antibacterial activityantibiotic resistancedihydropyrrol-2-oneorganoselenium compoundsPseudomonas aeruginosaquorum-sensing inhibitors

Identifiers

PMID33808733
PMCPMC8003518
OpenAlexW3137486126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.